Lucila Garcia-Contreras, Ph.D.
Associate Professor
Pharmaceutical Sciences
Phone (405) 271-6593 x47205
Fax (405) 271-7505
Office CPB 321
Summary
The research goal of my laboratory is “Targeted Drug Delivery” and involves the rational design of dosage forms and their in vitro evaluation, which are used to design in vivo studies. In turn, the information obtained in in vitro and in vivo studies is used to understand the underlying reasons of the performance of the dosage form with the objective of improving its formulation design to achieve the desired therapeutic effect.
A recent project that illustrates this process is the formulation of a novel molecule with anticancer and antimicrobial activity for pulmonary delivery as nanocrystals or microparticles. In vitro evaluation included size analysis using Scanning Electron Microscopy (SEM) and laser diffraction; stability, using (Fourier-transform infrared spectroscopy (FTIR), X-ray diffraction (XRD) and differential scanning calorimetry (DSC). We determined the aerosol performance of these formulations using commercial dry powder inhalers and performed pharmacokinetic studies to determine the disposition of the drug after pulmonary administration to mice. Lastly, in collaboration with Dr. Jie Wu from the OUHSC Department of Pathology, we assessed the efficacy of the nanocrystals in a transgenic mouse model of adenocarcinoma.
My laboratory also designs dosage forms for oral, vaginal and transdermal administration following same procedure. A second line of investigation of my laboratory is the development of needle-less vaccines to provide mucosal and systemic immunization. We are interested in elucidating the role of cell mediated immune (CMI) response and humoral immunity to the overall protection provided by the vaccine. Examples of vaccines studied in my laboratory include vaccines against tuberculosis, West Nile Virus, Diphtheria and Shigellosis.
Publications & Presentations
- 51. Hatipoglu S M, Mahjabeen S, Benbrook D M, Garcia-Contreras L. Development and Validation of Reverse Phase HPLC Method for SHetA2 in Gynecological Tissue for Treatment of Cervical Dysplasia. American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition. 2016
52. Ibrahim M, Hatipoglu S M, Benbrook D M, Garcia-Contreras L. Dissolution Studies for Inhalable Sheta2 Dry Powder Using a Novel Flow-Through Cell Apparatus. American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition. 2016
53. Mahjabeen S, Chandra V, Hatipoglu S M, Benbrook D M, Garcia-Contreras L. Formulation of SHetA2 in a Vaginal Suppository for Chemoprevention Against Cervical Dysplasia. American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition. 2016
54. Ibrahim M, Benbrook D M, Garcia-Contreras L. In Vitro Uptake of Inhalable SHetA2 Microparticles by RAW Macrophages and Their Efficacy against Intracellular Mycobacterium Tuberculosis. American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition. 2016
55. Hatipoglu S M, Yari H, Benbrook D M, Garcia-Contreras L. SHetA2 Nanocrystals as Novel Therapy to Treat Lung Cancer: Formulation and Characterization. American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition. 2016
Grants
- 16. Inhaled Caprazamycin for Tuberculosis Therapy . NIH. Start Date: 2011. End Date: 2015.
17. Inhaled SHetA2 (NSC 721689) dry powder aerosols as novel treatment for tuberculosis. State Agency. Start Date: 2014. End Date: 2015.
18. An inhaled dry powder formulation for the treatment multi-drug resistant tuberculosis. NIH. Start Date: 2013. End Date: 2014.
19. DEVELOPMENT OF CATIONIC PEPTIDE ADJUVANTS AND FORMULATIONS FOR A BIODEFENSE VACCINE. NIH. Start Date: 2011. End Date: 2014.
Awards and Honors
- 1. University of Oklahoma Health Sciences Center. Carlisle and Lurline Mabrey Presidential Professorship. Date: 2020.
2. Respiratory Drug Delivery. Posters on the podium. Date: 2012.
3. Graduate Research Association of Students in Pharmaceutics Best poster presentation. Date: 1997.
4. Fulbright. Fulbright-Conacyt Scholarship. Date: 1993.
5. National Autonomous University of Mexico. Gabino Barreda Medal-UNAM. Date: 1991.
Education
- 1. Degree: Post doctoral education. the University of North Carolina at Chapel Hill. Date: 2001.
2. Degree: Ph D. The University of Georgia. Date: 1999.
3. Degree: MS. The University of Georgia. Date: 1995.
4. Degree: Chemist Pharmacist Biologist. National Autonomous University of Mexico. Date: 1991.
Administrative Assignments
no results